name,category,termsATP-binding cassette, sub-family A (ABC1), member 5,COG_ONTOLOGY[90000055$Defense mechanisms]
ATP-binding cassette, sub-family A (ABC1), member 5,INTERPRO[450003006$IPR003439:ABC transporter-like, 450003154$IPR003593:ATPase, AAA+ type, core, 450016190$IPR017871:ABC transporter, conserved site]
ATP-binding cassette, sub-family A (ABC1), member 5,KEGG_PATHWAY[470038812$hsa02010:ABC transporters]
ATP-binding cassette, sub-family A (ABC1), member 5,SMART[760000335$SM00382:AAA]
ATP-binding cassette, sub-family A (ABC1), member 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000501$endosome, 790000616$glycoprotein, 790000624$golgi apparatus, 790000897$lysosome, 790000919$membrane, 790001063$nucleotide-binding, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
ATP-binding cassette, sub-family A (ABC1), member 5,UP_SEQ_FEATURE[850006540$chain:ATP-binding cassette sub-family A member 5, 850102998$domain:ABC transporter 1, 850102999$domain:ABC transporter 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850106264$nucleotide phosphate-binding region:ATP 1, 850106265$nucleotide phosphate-binding region:ATP 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R),BIOCARTA[30000307$h_vegfPathway:VEGF, Hypoxia, and Angiogenesis]
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R),INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450002084$IPR002343:Paraneoplastic encephalomyelitis antigen, 450005971$IPR006548:Splicing factor ELAV/HuD, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R),SMART[760000328$SM00360:RRM]
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R),SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000953$methylation, 790001162$phosphoprotein, 790001304$repeat, 790001339$rna-binding]
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R),UP_SEQ_FEATURE[850017033$chain:ELAV-like protein 1, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850105214$domain:RRM 3, 850106258$modified residue, 850117294$sequence conflict]
MIT, microtubule interacting and transport, domain containing 1,INTERPRO[450006694$IPR007330:MIT]
MIT, microtubule interacting and transport, domain containing 1,SMART[760000651$SM00745:MIT]
MIT, microtubule interacting and transport, domain containing 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000501$endosome, 790000919$membrane, 790001266$protein transport, 790001558$transport]
MIT, microtubule interacting and transport, domain containing 1,UP_SEQ_FEATURE[850031808$chain:MIT domain-containing protein 1, 850104790$domain:MIT, 850117294$sequence conflict]
NLR family, pyrin domain containing 12,INTERPRO[450003539$IPR004020:Pyrin, 450006487$IPR007111:NACHT nucleoside triphosphatase, 450010009$IPR011029:DEATH-like]
NLR family, pyrin domain containing 12,OMIM_DISEASE[520001860$Familial cold autoinflammatory syndrome 2]
NLR family, pyrin domain containing 12,PIR_SUPERFAMILY[630029074$PIRSF037494:NALP protein]
NLR family, pyrin domain containing 12,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000853$leucine-rich repeat, 790001063$nucleotide-binding, 790001212$polymorphism, 790001304$repeat]
NLR family, pyrin domain containing 12,UP_SEQ_FEATURE[850033383$chain:NACHT, LRR and PYD domains-containing protein 12, 850103482$domain:DAPIN, 850104825$domain:NACHT, 850106263$nucleotide phosphate-binding region:ATP, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
SMAD specific E3 ubiquitin protein ligase 2,COG_ONTOLOGY[90000102$RNA processing and modification]
SMAD specific E3 ubiquitin protein ligase 2,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450000485$IPR000569:HECT, 450001055$IPR001202:WW/Rsp5/WWP, 450016334$IPR018029:C2 membrane targeting protein]
SMAD specific E3 ubiquitin protein ligase 2,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis, 470038841$hsa04144:Endocytosis, 470038850$hsa04350:TGF-beta signaling pathway]
SMAD specific E3 ubiquitin protein ligase 2,PIR_SUPERFAMILY[630001740$PIRSF001569:E3 ubiquitin-protein ligase, Nedd4/Rsp5p types, 630030673$PIRSF500454:smad ubiquitination regulatory factor]
SMAD specific E3 ubiquitin protein ligase 2,SMART[760000104$SM00119:HECTc, 760000211$SM00239:C2, 760000401$SM00456:WW]
SMAD specific E3 ubiquitin protein ligase 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000859$ligase, 790000919$membrane, 790001065$nucleus, 790001304$repeat, 790001592$ubl conjugation, 790001593$ubl conjugation pathway]
SMAD specific E3 ubiquitin protein ligase 2,UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850016754$chain:E3 ubiquitin-protein ligase SMURF2, 850103199$domain:C2, 850104105$domain:HECT, 850105732$domain:WW 1, 850105733$domain:WW 2, 850105734$domain:WW 3, 850105852$helix, 850106259$mutagenesis site, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
WD repeat domain 6,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
WD repeat domain 6,SMART[760000289$SM00320:WD40]
WD repeat domain 6,SP_PIR_KEYWORDS[790000356$complete proteome, 790000924$membrane protein, 790001304$repeat, 790001638$wd repeat]
WD repeat domain 6,UP_SEQ_FEATURE[850100762$chain:WD repeat-containing protein 6, 850117171$repeat:WD 1, 850117172$repeat:WD 10, 850117173$repeat:WD 11, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117199$repeat:WD 8, 850117200$repeat:WD 9]
adenylate cyclase 2 (brain),INTERPRO[450000923$IPR001054:Adenylyl cyclase class-3/4/guanylyl cyclase, 450008505$IPR009398:Adenylate cyclase-like, 450016581$IPR018297:Adenylyl cyclase class-3/4/guanylyl cyclase, conserved site]
adenylate cyclase 2 (brain),KEGG_PATHWAY[470038742$hsa00230:Purine metabolism, 470038829$hsa04020:Calcium signaling pathway, 470038831$hsa04062:Chemokine signaling pathway, 470038835$hsa04114:Oocyte meiosis, 470038845$hsa04270:Vascular smooth muscle contraction, 470038858$hsa04540:Gap junction, 470038883$hsa04912:GnRH signaling pathway, 470038884$hsa04914:Progesterone-mediated oocyte maturation, 470038885$hsa04916:Melanogenesis, 470038922$hsa05414:Dilated cardiomyopathy]
adenylate cyclase 2 (brain),PIR_SUPERFAMILY[630001609$PIRSF001445:adenylate cyclase]
adenylate cyclase 2 (brain),SMART[760000036$SM00044:CYCc]
adenylate cyclase 2 (brain),SP_PIR_KEYWORDS[790000138$atp-binding, 790000222$camp biosynthesis, 790000356$complete proteome, 790000616$glycoprotein, 790000891$lyase, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001167$phosphorus-oxygen lyase, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane]
adenylate cyclase 2 (brain),UP_SEQ_FEATURE[850003893$chain:Adenylate cyclase type 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850106134$metal ion-binding site:Magnesium 1, 850106137$metal ion-binding site:Magnesium 2, 850106139$metal ion-binding site:Magnesium 2; via carbonyl oxygen, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118623$transmembrane region]
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit,INTERPRO[450001840$IPR002077:Voltage-dependent calcium channel, alpha-1 subunit, 450004906$IPR005447:Voltage-dependent calcium channel, N-type, alpha-1 subunit, 450004907$IPR005448:Voltage-dependent calcium channel, P/Q-type, alpha-1 subunit, 450005268$IPR005821:Ion transport, 450013322$IPR014873:Voltage-dependent calcium channel, alpha-1 subunit, IQ domain]
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038829$hsa04020:Calcium signaling pathway, 470038878$hsa04730:Long-term depression, 470038880$hsa04742:Taste transduction, 470038887$hsa04930:Type II diabetes mellitus]
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit,OMIM_DISEASE[520000894$Cerebellar ataxia, pure, 520001785$Episodic ataxia, type 2, 520002248$Hemiplegic migraine, familial, 520004638$Spinocerebellar ataxia-6]
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit,PIR_SUPERFAMILY[630005588$PIRSF005657:voltage-gated calcium channel]
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000211$calcium, 790000213$calcium channel, 790000215$calcium transport, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001015$neurodegeneration, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001431$spinocerebellar ataxia, 790001555$transmembrane, 790001558$transport, 790001569$triplet repeat expansion, 790001631$voltage-gated channel]
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit,UP_SEQ_FEATURE[850100541$chain:Voltage-dependent P/Q-type calcium channel subunit alpha-1A, 850102566$compositionally biased region:Poly-Arg, 850102570$compositionally biased region:Poly-Gln, 850102572$compositionally biased region:Poly-Glu, 850102573$compositionally biased region:Poly-Gly, 850102574$compositionally biased region:Poly-His, 850102580$compositionally biased region:Poly-Pro, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850111061$region of interest:Binding to the beta subunit, 850116205$repeat:I, 850116211$repeat:II, 850116226$repeat:III, 850116236$repeat:IV, 850117294$sequence conflict, 850117295$sequence variant, 850117960$site:Calcium ion selectivity and permeability, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
carcinoembryonic antigen-related cell adhesion molecule 8,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
carcinoembryonic antigen-related cell adhesion molecule 8,SMART[760000357$SM00409:IG]
carcinoembryonic antigen-related cell adhesion molecule 8,SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000628$gpi-anchor, 790000768$Immunoglobulin domain, 790000881$lipoprotein, 790000919$membrane, 790001149$phosphatidylinositol linkage, 790001212$polymorphism, 790001304$repeat, 790001405$signal]
carcinoembryonic antigen-related cell adhesion molecule 8,UP_SEQ_FEATURE[850009694$chain:Carcinoembryonic antigen-related cell adhesion molecule 8, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850105858$lipid moiety-binding region:GPI-anchor amidated aspartate, 850109701$propeptide:Removed in mature form, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118624$turn]
chromosome 17 open reading frame 81,INTERPRO[450017756$IPR019519:Histone acetylation protein 2]
chromosome 17 open reading frame 81,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
chromosome 17 open reading frame 81,UP_SEQ_FEATURE[850014909$chain:Dermal papilla-derived protein 6, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
cytochrome P450, family 3, subfamily A, polypeptide 7,COG_ONTOLOGY[90000104$Secondary metabolites biosynthesis, transport, and catabolism]
cytochrome P450, family 3, subfamily A, polypeptide 7,INTERPRO[450000989$IPR001128:Cytochrome P450, 450002135$IPR002402:Cytochrome P450, E-class, group II, 450007409$IPR008072:Cytochrome P450, E-class, CYP3A, 450016280$IPR017972:Cytochrome P450, conserved site, 450016281$IPR017973:Cytochrome P450, C-terminal region]
cytochrome P450, family 3, subfamily A, polypeptide 7,KEGG_PATHWAY[470038739$hsa00140:Steroid hormone biosynthesis, 470038781$hsa00591:Linoleic acid metabolism, 470038801$hsa00830:Retinol metabolism, 470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450, 470038809$hsa00982:Drug metabolism, 470038810$hsa00983:Drug metabolism]
cytochrome P450, family 3, subfamily A, polypeptide 7,PIR_SUPERFAMILY[630000064$PIRSF000051:cytochrome P450 CYP3A5, 630000065$PIRSF000052:trichodiene oxygenase]
cytochrome P450, family 3, subfamily A, polypeptide 7,SP_PIR_KEYWORDS[790000314$chromoprotein, 790000356$complete proteome, 790000445$direct protein sequencing, 790000488$electron transfer, 790000499$endoplasmic reticulum, 790000652$heme, 790000802$iron, 790000919$membrane, 790000937$metal-binding, 790000943$metalloprotein, 790000959$microsome, 790000984$Monooxygenase, 790001092$oxidoreductase, 790001212$polymorphism, 790001556$transmembrane protein]
cytochrome P450, family 3, subfamily A, polypeptide 7,UP_SEQ_FEATURE[850013780$chain:Cytochrome P450 3A7, 850106026$metal ion-binding site:Iron (heme axial ligand), 850117295$sequence variant]
dihydropyrimidinase-like 5,INTERPRO[450006091$IPR006680:Amidohydrolase 1, 450010604$IPR011778:D-hydantoinase]
dihydropyrimidinase-like 5,KEGG_PATHWAY[470038851$hsa04360:Axon guidance]
dihydropyrimidinase-like 5,PIR_SUPERFAMILY[630001385$PIRSF001238:cyclic amidohydrolases (dihydroorotase, allantoinase)]
dihydropyrimidinase-like 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790001162$phosphoprotein]
dihydropyrimidinase-like 5,UP_SEQ_FEATURE[850015147$chain:Dihydropyrimidinase-related protein 5, 850106258$modified residue, 850117294$sequence conflict]
eukaryotic translation initiation factor 4E nuclear import factor 1,INTERPRO[450017134$IPR018862:Eukayotic translation initiation factor 4E transporter]
eukaryotic translation initiation factor 4E nuclear import factor 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000776$Initiation factor, 790001065$nucleus, 790001162$phosphoprotein, 790001266$protein transport, 790001558$transport]
eukaryotic translation initiation factor 4E nuclear import factor 1,UP_SEQ_FEATURE[850018131$chain:Eukaryotic translation initiation factor 4E transporter, 850102404$compositionally biased region:Arg-rich, 850106258$modified residue, 850106259$mutagenesis site, 850111571$region of interest:EIF4E-binding, 850117294$sequence conflict, 850117605$short sequence motif:Nuclear export signal, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant]
growth arrest and DNA-damage-inducible, beta,INTERPRO[450003556$IPR004038:Ribosomal protein L7Ae/L30e/S12e/Gadd45]
growth arrest and DNA-damage-inducible, beta,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038834$hsa04110:Cell cycle, 470038836$hsa04115:p53 signaling pathway]
growth arrest and DNA-damage-inducible, beta,PIR_SUPERFAMILY[630009191$PIRSF010369:growth arrest and DNA-damage-inducible protein GADD45]
growth arrest and DNA-damage-inducible, beta,SP_PIR_KEYWORDS[790000109$Apoptosis, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation]
growth arrest and DNA-damage-inducible, beta,UP_SEQ_FEATURE[850022448$chain:Growth arrest and DNA-damage-inducible protein GADD45 beta, 850117294$sequence conflict]
haloacid dehalogenase-like hydrolase domain containing 3,COG_ONTOLOGY[90000073$General function prediction only]
haloacid dehalogenase-like hydrolase domain containing 3,INTERPRO[450005280$IPR005833:Haloacid dehydrogenase/epoxide hydrolase, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005861$IPR006439:HAD-superfamily hydrolase, subfamily IA, variant 1, 450010774$IPR011949:HAD-superfamily hydrolase, subfamily IA, REG-2-like]
haloacid dehalogenase-like hydrolase domain containing 3,PIR_SUPERFAMILY[630001034$PIRSF000895:phosphoglycolate phosphatase]
haloacid dehalogenase-like hydrolase domain containing 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790001212$polymorphism]
haloacid dehalogenase-like hydrolase domain containing 3,UP_SEQ_FEATURE[850022919$chain:Haloacid dehalogenase-like hydrolase domain-containing protein 3, 850106258$modified residue, 850117295$sequence variant]
kelch domain containing 3,INTERPRO[450006067$IPR006652:Kelch repeat type 1, 450010360$IPR011498:Kelch repeat type 2, 450014332$IPR015915:Kelch-type beta propeller]
kelch domain containing 3,SMART[760000541$SM00612:Kelch]
kelch domain containing 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000819$kelch repeat, 790000915$meiosis, 790001304$repeat]
kelch domain containing 3,UP_SEQ_FEATURE[850027087$chain:Kelch domain-containing protein 3, 850116239$repeat:Kelch 1, 850116250$repeat:Kelch 2, 850116251$repeat:Kelch 3, 850116252$repeat:Kelch 4, 850116253$repeat:Kelch 5]
kinesin light chain 4,INTERPRO[450001282$IPR001440:Tetratricopeptide TPR-1, 450001908$IPR002151:Kinesin light chain, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450013832$IPR015390:Rabaptin, GTPase-Rab5 binding, 450014226$IPR015792:Kinesin light chain repeat, 450017972$IPR019734:Tetratricopeptide repeat]
kinesin light chain 4,SMART[760000020$SM00028:TPR]
kinesin light chain 4,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000960$microtubule, 790000986$motor protein, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001537$tpr repeat]
kinesin light chain 4,UP_SEQ_FEATURE[850027439$chain:Kinesin light chain 4, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117143$repeat:TPR 5, 850117144$repeat:TPR 6, 850117145$repeat:TPR 7, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
neurensin 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
neurensin 2,UP_SEQ_FEATURE[850033917$chain:Neurensin-2, 850117295$sequence variant, 850118623$transmembrane region]
nuclear receptor subfamily 2, group F, member 6,INTERPRO[450000459$IPR000536:Nuclear hormone receptor, ligand-binding, core, 450001442$IPR001628:Zinc finger, nuclear hormone receptor-type, 450001527$IPR001723:Steroid hormone receptor, 450002694$IPR003068:Transcription factor COUP, 450008168$IPR008946:Nuclear hormone receptor, ligand-binding, 450011732$IPR013088:Zinc finger, NHR/GATA-type, 450012253$IPR013629:Zinc finger-associated region]
nuclear receptor subfamily 2, group F, member 6,PIR_SUPERFAMILY[630002651$PIRSF002534:retinoic X receptor-like nuclear receptor, 630031001$PIRSF500849:orphan nuclear receptor COUP-TF]
nuclear receptor subfamily 2, group F, member 6,SMART[760000350$SM00399:ZnF_C4, 760000376$SM00430:HOLI]
nuclear receptor subfamily 2, group F, member 6,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001301$receptor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
nuclear receptor subfamily 2, group F, member 6,UP_SEQ_FEATURE[850035055$chain:Nuclear receptor subfamily 2 group F member 6, 850102946$DNA-binding region:Nuclear receptor, 850106258$modified residue, 850117294$sequence conflict, 850118866$zinc finger region:NR C4-type]
nucleolar protein family 6 (RNA-associated),INTERPRO[450005006$IPR005554:Nrap protein]
nucleolar protein family 6 (RNA-associated),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001339$rna-binding]
nucleolar protein family 6 (RNA-associated),UP_SEQ_FEATURE[850035192$chain:Nucleolar protein 6, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
phosphatidylinositol-5-phosphate 4-kinase, type II, beta,INTERPRO[450002217$IPR002498:Phosphatidylinositol-4-phosphate 5-kinase, core, 450014423$IPR016034:Phosphatidylinositol-4-phosphate 5-kinase, core, subgroup]
phosphatidylinositol-5-phosphate 4-kinase, type II, beta,KEGG_PATHWAY[470038776$hsa00562:Inositol phosphate metabolism, 470038832$hsa04070:Phosphatidylinositol signaling system, 470038841$hsa04144:Endocytosis, 470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038881$hsa04810:Regulation of actin cytoskeleton]
phosphatidylinositol-5-phosphate 4-kinase, type II, beta,PIR_SUPERFAMILY[630000793$PIRSF000679:phosphatidylinositol-4-phosphate 5-kinase type II alpha]
phosphatidylinositol-5-phosphate 4-kinase, type II, beta,SMART[760000299$SM00330:PIPKc]
phosphatidylinositol-5-phosphate 4-kinase, type II, beta,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000264$cell membrane, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000825$kinase, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001547$transferase]
phosphatidylinositol-5-phosphate 4-kinase, type II, beta,UP_SEQ_FEATURE[850038473$chain:Phosphatidylinositol-5-phosphate 4-kinase type-2 beta, 850104999$domain:PIPK, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
proteasome (prosome, macropain) subunit, beta type, 6,INTERPRO[450000211$IPR000243:Peptidase T1A, proteasome beta-subunit, 450001196$IPR001353:Proteasome, alpha and beta subunits, 450001197$IPR001353:Proteasome, subunit alpha/beta, 450014435$IPR016050:Proteasome, beta-type subunit, conserved site]
proteasome (prosome, macropain) subunit, beta type, 6,KEGG_PATHWAY[470038819$hsa03050:Proteasome]
proteasome (prosome, macropain) subunit, beta type, 6,PIR_SUPERFAMILY[630001355$PIRSF001214:multicatalytic endopeptidase complex chain C5]
proteasome (prosome, macropain) subunit, beta type, 6,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000733$host-virus interaction, 790000743$hydrolase, 790001065$nucleus, 790001212$polymorphism, 790001252$Protease, 790001254$proteasome, 790001267$proteinase, 790001516$threonine protease, 790001652$zymogen]
proteasome (prosome, macropain) subunit, beta type, 6,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850044892$chain:Proteasome subunit beta type-6, 850106258$modified residue, 850109701$propeptide:Removed in mature form, 850117294$sequence conflict, 850117295$sequence variant]
serine threonine kinase 39 (STE20/SPS1 homolog, yeast),INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
serine threonine kinase 39 (STE20/SPS1 homolog, yeast),OMIM_DISEASE[520005092$Whole-genome association study identifies STK39 as a hypertension susceptibility gene]
serine threonine kinase 39 (STE20/SPS1 homolog, yeast),SMART[760000193$SM00220:S_TKc]
serine threonine kinase 39 (STE20/SPS1 homolog, yeast),SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001388$serine/threonine-protein kinase, 790001547$transferase]
serine threonine kinase 39 (STE20/SPS1 homolog, yeast),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850062409$chain:STE20/SPS1-related proline-alanine-rich protein kinase, 850102397$compositionally biased region:Ala/Pro-rich, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117333$short sequence motif:Caspase cleavage related site, 850117610$short sequence motif:Nuclear localization signal]
staufen, RNA binding protein, homolog 2 (Drosophila),INTERPRO[450001016$IPR001159:Double-stranded RNA binding, 450013172$IPR014720:Double-stranded RNA-binding-like]
staufen, RNA binding protein, homolog 2 (Drosophila),SMART[760000326$SM00358:DSRM]
staufen, RNA binding protein, homolog 2 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000499$endoplasmic reticulum, 790000960$microtubule, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding, 790001558$transport]
staufen, RNA binding protein, homolog 2 (Drosophila),UP_SEQ_FEATURE[850016330$chain:Double-stranded RNA-binding protein Staufen homolog 2, 850103546$domain:DRBM 1, 850103547$domain:DRBM 2, 850103548$domain:DRBM 3, 850103549$domain:DRBM 4, 850106258$modified residue, 850114283$region of interest:Required for dendritic transport, 850117294$sequence conflict, 850117295$sequence variant, 850117611$short sequence motif:Nuclear localization signal 1, 850117612$short sequence motif:Nuclear localization signal 2, 850118574$splice variant]
strawberry notch homolog 2 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
strawberry notch homolog 2 (Drosophila),UP_SEQ_FEATURE[850047882$chain:Protein strawberry notch homolog 2, 850102572$compositionally biased region:Poly-Glu, 850102586$compositionally biased region:Pro-rich, 850117294$sequence conflict, 850118574$splice variant]
tetratricopeptide repeat domain 15,INTERPRO[450001282$IPR001440:Tetratricopeptide TPR-1, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450017972$IPR019734:Tetratricopeptide repeat]
tetratricopeptide repeat domain 15,SMART[760000020$SM00028:TPR]
tetratricopeptide repeat domain 15,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001537$tpr repeat]
tetratricopeptide repeat domain 15,UP_SEQ_FEATURE[850063998$chain:Tetratricopeptide repeat protein 15, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117294$sequence conflict, 850117295$sequence variant]
wingless-type MMTV integration site family, member 16,INTERPRO[450005264$IPR005816:Secreted growth factor Wnt protein, 450005265$IPR005817:Wnt superfamily, 450011940$IPR013304:Wnt-16 protein, 450016453$IPR018161:Secreted growth factor Wnt protein, conserved site]
wingless-type MMTV integration site family, member 16,KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway, 470038849$hsa04340:Hedgehog signaling pathway, 470038885$hsa04916:Melanogenesis, 470038899$hsa05200:Pathways in cancer, 470038907$hsa05217:Basal cell carcinoma]
wingless-type MMTV integration site family, member 16,PIR_SUPERFAMILY[630001927$PIRSF001784:int-1 transforming protein]
wingless-type MMTV integration site family, member 16,SMART[760000085$SM00097:WNT1]
wingless-type MMTV integration site family, member 16,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790000530$extracellular matrix, 790000616$glycoprotein, 790001212$polymorphism, 790001363$Secreted, 790001405$signal, 790001642$wnt signaling pathway]
wingless-type MMTV integration site family, member 16,UP_SEQ_FEATURE[850048416$chain:Protein Wnt-16, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
zinc finger and SCAN domain containing 21,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger and SCAN domain containing 21,INTERPRO[450002887$IPR003309:Transcriptional regulator SCAN, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger and SCAN domain containing 21,SMART[760000323$SM00355:ZnF_C2H2, 760000377$SM00431:SCAN]
zinc finger and SCAN domain containing 21,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger and SCAN domain containing 21,UP_SEQ_FEATURE[850101271$chain:Zinc finger and SCAN domain-containing protein 21, 850105271$domain:SCAN box, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7]
zinc finger protein 318,INTERPRO[450003164$IPR003604:Zinc finger, U1-type, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 318,SMART[760000323$SM00355:ZnF_C2H2, 760000396$SM00451:ZnF_U1]
zinc finger protein 318,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000915$meiosis, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 318,UP_SEQ_FEATURE[850101568$chain:Zinc finger protein 318, 850102554$compositionally biased region:Lys-rich, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118836$zinc finger region:Matrin-type 1, 850118837$zinc finger region:Matrin-type 2]
zinc finger protein 491,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 491,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 491,SMART[760000323$SM00355:ZnF_C2H2]
zinc finger protein 491,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 491,UP_SEQ_FEATURE[850101686$chain:Zinc finger protein 491, 850118657$zinc finger region:C2H2-type 10, 850118660$zinc finger region:C2H2-type 11, 850118663$zinc finger region:C2H2-type 12, 850118666$zinc finger region:C2H2-type 13, 850118686$zinc finger region:C2H2-type 1; degenerate, 850118709$zinc finger region:C2H2-type 2; degenerate, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
zinc finger protein 541,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 541,INTERPRO[450000828$IPR000949:ELM2, 450000876$IPR001005:SANT, DNA-binding, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450013228$IPR014778:Myb, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like, 450016201$IPR017884:SANT, eukarya]
zinc finger protein 541,SMART[760000323$SM00355:ZnF_C2H2, 760000623$SM00717:SANT]
zinc finger protein 541,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001307$repressor, 790001426$spermatogenesis, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 541,UP_SEQ_FEATURE[850101723$chain:Zinc finger protein 541, 850103712$domain:ELM2, 850105254$domain:SANT, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5]
zinc finger protein 782,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 782,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 782,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 782,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 782,UP_SEQ_FEATURE[850101914$chain:Zinc finger protein 782, 850104552$domain:KRAB, 850117295$sequence variant, 850118657$zinc finger region:C2H2-type 10, 850118660$zinc finger region:C2H2-type 11, 850118663$zinc finger region:C2H2-type 12, 850118666$zinc finger region:C2H2-type 13, 850118669$zinc finger region:C2H2-type 14, 850118671$zinc finger region:C2H2-type 15, 850118686$zinc finger region:C2H2-type 1; degenerate, 850118709$zinc finger region:C2H2-type 2; degenerate, 850118721$zinc finger region:C2H2-type 3; degenerate, 850118724$zinc finger region:C2H2-type 4; degenerate, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
